X-154953991-G-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000132.4(F8):āc.1804C>Gā(p.Arg602Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000364 in 1,097,407 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.1804C>G | p.Arg602Gly | missense_variant | 12/26 | ENST00000360256.9 | NP_000123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.1804C>G | p.Arg602Gly | missense_variant | 12/26 | 1 | NM_000132.4 | ENSP00000353393.4 | ||
F8 | ENST00000647125.1 | n.*1680C>G | non_coding_transcript_exon_variant | 13/14 | ENSP00000496062.1 | |||||
F8 | ENST00000647125.1 | n.*1680C>G | 3_prime_UTR_variant | 13/14 | ENSP00000496062.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1097407Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 1AN XY: 362779
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 08, 2019 | The F8 c.1804C>G (p.Arg602Gly) missense variant that has been reported in at least two studies and is identified in a hemizygous state in at least eight individuals with mild hemophilia A (Bowyer et al. 2013; Beskorovainaya et al. 2019). Control data are unavailable for this variant, which is not found in in the Genome Aggregation Database despite good sequence coverage, so the variant is presumed to be rare. Based on the prevalence of the variant in affected individuals compared to controls, absence from population frequency databases, and location in a functional domain in a variant hotspot, the p.Arg602Gly variant is classified as likely pathogenic for hemophilia A. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 10, 2023 | Variant summary: F8 c.1804C>G (p.Arg602Gly) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183429 control chromosomes. c.1804C>G has been reported in the literature in multiple individuals affected with mild Factor VIII Deficiency (Hemophilia A) (example, Hill_2005, Green_2008, Miller_2012, Eckhardt_2013, Downes_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31064749, 23926300, 18691168, 15810915, 22103590). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Hereditary factor IX deficiency disease Pathogenic:1
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Feb 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at